# Innovation Validation Call

**Funder:** EIT Health
**Budget:** Up to €850,000 per project (max 50% of total project budget); micro/small enterprises must receive €400,000–€500,000
**Deadline:** 13 January 2027
**Consortium:** Required — minimum 2 organisations from different countries, representing at least 2 sides of the Knowledge Triangle (industry, research, education), led by a commercialising company
**Application:** Single stage
**Frequency:** Annual
**Next round:** 2027-10
**Official call:** https://eithealth.eu/opportunity/innovation-validation/
**Last updated:** 18 Oct 2026

## Eligibility & scope

Supports digital/AI-enabled medical devices (MDR/IVDR) at Innovation Maturity Level 6 aiming to reach IML 7, funding clinical validation, regulatory submission (CE-mark), product finalisation and market readiness. Commercialising entity must sign a Financial Sustainability Contribution Agreement.

## Summary

The EIT Health Innovation Validation Call funds up to €850,000 per project (capped at 50% of total costs) to take digital or AI-enabled medical devices from Innovation Maturity Level 6 to 7, covering clinical validation, regulatory submission and CE-marking, and market readiness. It targets consortia led by a commercialising company, with micro and small enterprises required to receive €400,000-€500,000 of the award. Applicants must team up with partners from different countries spanning at least two sides of the Knowledge Triangle, industry, research, and education.

## Who should apply

- Commercialising companies developing digital or AI-enabled medical devices under MDR/IVDR
- Projects at Innovation Maturity Level 6 seeking to reach IML 7
- Consortia with partners from at least two different countries
- Teams spanning at least two sides of the Knowledge Triangle (industry, research, education)
- Micro and small enterprises positioned to receive €400,000-€500,000 of project funding

## Key dates

- Application deadline: 13 January 2027
- Single-stage application process
- Annual call, with the next round expected around October 2027

## Tips for applicants

- Budget planning must route €400,000-€500,000 to the micro or small enterprise partner specifically, structure the consortium finances around this early.
- The commercialising company must sign a Financial Sustainability Contribution Agreement, so clarify this commitment with leadership before applying.
- Frame the work plan explicitly around the IML 6-to-7 transition: clinical validation, CE-mark submission and market readiness, not earlier-stage R&D.

## Frequently asked questions

### How much funding does the EIT Health Innovation Validation Call provide?

Up to €850,000 per project, capped at 50% of total project budget, with micro/small enterprises required to receive €400,000-€500,000.

### Who can apply to the EIT Health Innovation Validation Call?

Consortia led by a commercialising company, with at least two organisations from different countries representing at least two sides of the Knowledge Triangle (industry, research, education).

### What stage of development must the project be at?

Projects must be at Innovation Maturity Level 6 and aim to reach IML 7 through clinical validation, regulatory submission and market readiness.

### Is the EIT Health Innovation Validation Call a recurring programme?

Yes, it runs annually, with the next round expected around October 2027.

### Does the call require a consortium agreement?

Yes, and the commercialising entity must also sign a Financial Sustainability Contribution Agreement.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/eit-health-innovation-validation-call-2027-01) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=eit-health-innovation-validation-call-2027-01).